Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2020-08-01
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sonographic Venous Doppler Imaging in Acute Kidney Injury
NCT04948710
Point-of-care Ultrasound to Assess Hydronephrosis in Patients With Acute Kidney Injury in the Emergency Department
NCT06040736
Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury
NCT05409690
Sonographic Venous Doppler Imaging in End-Stage Renal Disease
NCT05337384
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
NCT04095143
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ultrasonography
Point-of-care ultrasound:
1. Kidney length and echogenity,
2. Bladder scanning
3. VCI measures
4. Lung B lines and effusion
5. Cardiac measurements; EF, TAPSE, TR Vmax, Diameters, LV filling pressures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Failure to perform POCUS in the first two hours of presentation of patient,
* Those with renal malignancy,
* Pregnant women,
* Renal transplantation patients,
* Patients with a single kidney,
* Those with polycystic kidney disease,
* Patients with nephrostomy,
* Patients who are referred from another center,
* Unable to perform adequate imaging,
* Patients who do not give consent for the study will be excluded.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mehmet Ali Aslaner
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Ali Aslaner
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet Aslaner, MD
Role: PRINCIPAL_INVESTIGATOR
Gazi University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gazi University Facaulty of Medicine
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GaziU-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.